Ireland Information and Enquiries

On 27 June, 2025, BioCryst announced the sale of our European business to Neopharmed Gentili. You can read the press release here.

Medicines in Ireland

The content on this page is intended for members of the public. Our current prescription medicines are listed below.

Logo with the text "Orladeyo (berotralstat) capsules 150mg"

ORLADEYO® (berotralstat)

For complete information, consult the Summary of Product Characteristics (SmPC) and the Notice on ema.europe.eu.

Customer Assistance

Medical Information

For medical information:
medinfoeurope@biocryst.com or
+353 1 699 4405

Adverse events/product complaints

Adverse events should be reported to BioCryst at:
medinfoeurope@biocryst.com or
+353 1 699 4405

General enquiries

For general enquiries:
enquiriesireland@biocryst.com

BioCryst Ireland Limited (office)

Block 4,
Harcourt Centre, Harcourt Road,
Dublin 2
D02 HW77
Ireland
+353 (1) 477 3087

Disclosures

Healthcare professionals: BioCryst complies with all transparency obligations imposed on pharmaceutical companies. We publish our links of interest with health professionals and organisations. Please visit https://www.transferofvalue.ie/ToVData/BCU for more information.

You are now leaving the the Ireland region website to go to another of our BioCryst websites. Marketing authorisations and availability of medicines may differ between Ireland and other countries. If you are happy to proceed, please click Confirm.

Confirm >>

You are now leaving the BioCryst Ireland website to go to an external website over which BioCryst has no control – marketing authorisations and availability of medicines may differ between Ireland and other countries. Furthermore, information about your person may be transmitted to the site and cookies may be operated by the website provider. If you are happy to proceed to the site, please click Confirm.

Confirm >>